Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

PROSAIC-19 - Prospective Longitudinal Assessment in a COVID-19 Infected Cohort

NCT04444609 is registered in ClinicalTrials.gov with Imperial College London as lead sponsor.

NCT NCT04444609
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04444609 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
PROSAIC-19 - Prospective Longitudinal Assessment in a COVID-19 Infected Cohort
Lead sponsor
Imperial College London
Phase
Observational
Overall status
Completed
Start date
June 18, 2020
Completion date
June 17, 2024
Enrollment
161 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ards, human, covid-19, immune system disorder, sars-cov 2